5281 - 5290 of 8580 Results
Title
Year
-
OPENTitle: Kinase inhibitors arrest neurodegeneration in cell and C. elegans models of LRRK2 toxicityJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 22Issue #: 2Start Page: 328End Page: 344Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/dds431Best OA location URL: https://academic.oup.com/hmg/article-pdf/22/2/328/1857445/dds431.pdfCitation Count: 76
-
OPENTitle: Asparagine endopeptidase cleaves α-synuclein and mediates pathologic activities in Parkinson's diseaseJournal Name: Nature Structural & Molecular BiologyPublisher: Springer Science and Business Media LLCVol: 24Issue #: 8Start Page: 632End Page: 642Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nsmb.3433Best OA location URL: https://www.nature.com/articles/nsmb.3433.pdfCitation Count: 169
-
OPENTitle: Mechanism of parkin activation by PINK1Journal Name: NaturePublisher: Springer Science and Business Media LLCVol: 559Issue #: 7714Start Page: 410End Page: 414Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41586-018-0224-xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6071873Citation Count: 326
-
OPENTitle: Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after EndocytosisJournal Name: NeuronPublisher: Elsevier BVVol: 65Issue #: 1Start Page: 66End Page: 79Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.neuron.2009.12.023Best OA location URL: http://www.cell.com/article/S0896627309010411/pdfCitation Count: 972
-
OPENTitle: Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodiesJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-015-0010-2Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-015-0010-2Citation Count: 137
-
OPENTitle: Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 7Issue #: 7Start Page: 583End Page: 590Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/s1474-4422(08)70117-0Best OA location URL: http://www.thelancet.com/article/S1474442208701170/pdfCitation Count: 1461
-
OPENTitle: The natural history of multiple system atrophy: a prospective European cohort studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 12Issue #: 3Start Page: 264End Page: 274Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/s1474-4422(12)70327-7Best OA location URL: http://www.thelancet.com/article/S1474442212703277/pdfCitation Count: 497
-
OPENTitle: Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65Journal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 460Issue #: 1Start Page: 127End Page: 141Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bj20140334Best OA location URL: https://portlandpress.com/biochemj/article-pdf/460/1/127/678769/bj4600127.pdfCitation Count: 765
- ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing2013OPENTitle: ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencingJournal Name: Genetics in MedicinePublisher: Elsevier BVVol: 15Issue #: 7Start Page: 565End Page: 574Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1038/gim.2013.73Best OA location URL: http://www.gimjournal.org/article/S1098360021027623/pdfCitation Count: 2415
-
OPENTitle: Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trialJournal Name: The LancetPublisher: Elsevier BVVol: 390Issue #: 10103Start Page: 1664End Page: 1675Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s0140-6736(17)31585-4Citation Count: 690